RXO Shares Surge 304 After Positive Analyst Outlook on Logistics Prospects Legal Scholars Challenge Trumps 18 Billion Fund Ancient Principles and Modern Precedents French Investors Shift to Real Assets as Safe Haven in First Quarter Indias Gen Z Cockroach Movement Gains Momentum Amid Exam Controversy Website Taken Down Microns Latest Breakthrough Dicks Earnings Beat and Key Political Shifts Lead Market Morning Senco Gold Q4 Profit Surges 151 to Rs 157 Crore on Strong Gold Prices and Wedding Demand Xenon Pharmaceuticals XENE Q1 2026 Earnings Narrowerthanexpected loss highlights operational progress Flowers Foods Q1 2026 Earnings EPS Surges Past Estimates as Stock Jumps 13 Jefferson Capital Inc JCAP Q1 2026 Earnings EPS Beats Estimates but Stock Slides on Mixed Signals Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings Narrower Net Loss Beats Estimates Amid Pipeline Progress BMRC Q1 2026 Earnings EPS Misses Estimates as Loan Portfolio Pressures Emerge Lineage Inc LINE Q1 2026 Earnings EPS Miss Sends Shares Higher Amid Operational Strength Birchtech Corp BCHT Edges Higher as Shares Test Support Zone Ingram Micro INGM Surges 338 Key Technical Signals in Play AGNCN Preferred Stock Holds Steady Near 2574 Amid Narrow Trading Range Caribou Biosciences CRBU Jumps 7 as GeneEditing Stock Approaches Key Resistance Splash Beverage Group SBEV Slides 357 to 016 Testing Key Support at 015 Healthcare and Tech Lead as Broad Market Edges Higher Myriad Genetics Q1 2026 Earnings EPS Miss Highlights Continued Operational Challenges Lincoln Electric Holdings LECO Edges Higher as Market Digests Steady Industrial Demand FIGS Inc Edges Higher as Stock Approaches Resistance Zone Transdigm Group TDG Holds Steady Near Key Support Levels Amid Modest Gains McKinley Acquisition Corporation Rights MKLYR Surges 40 Rights Trading at 014 BrandywineGLOBAL Global Income Opportunities Fund BWG Holds Steady Near Support as Yield Play Gains Attention Covista Inc CVSA Slides Marginally Holding Above Key Support LSI Industries LYTS Surges Nearly 3 as Bulls Approach Key Resistance Kymera Therapeutics KYMR Holds Near Resistance After Marginal Decline